Delphia (USA)’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,852
Closed -$293K 338
2022
Q3
$293K Sell
3,852
-1,618
-30% -$123K 0.33% 120
2022
Q2
$380K Buy
+5,470
New +$380K 0.26% 127